Earendil Labs Raises USD 787 Million to Scale AI-Driven Biologics Discovery
Earendil Labs will use its USD 787 million financing to scale its Artificial Intelligence (AI)-driven R&D platform, expand inter-disciplinary teams and advance a pipeline of antibody and biologics programmes targeting serious diseases.
Digitalization | 21/03/2026 | By News Bureau | 292
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.
Digitalization | 20/03/2026 | By News Bureau | 125
Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.
Digitalization | 18/03/2026 | By News Bureau | 165
Agilisium Invests INR 50 Crore to Accelerate AI Adoption in Life Sciences
Agilisium’s new forward deployment Artificial Intelligence (AI) model embeds specialised experts within life sciences organisations, enabling faster and practical adoption of AI by bridging the gap between innovation and real-world execution.
Digitalization | 18/03/2026 | By Akanki | 205
GenomOncology Partners with WeTrials to Accelerate Clinical Trial Access for CNS Cancer Patients
GenomOncology and WeTrials collaborate to streamline clinical trial enrollment for Central Nervous System Cancer patients, integrating genomic reports with AI-driven patient engagement tools through expanded partnership with Belay Diagnostics.
Digitalization | 11/03/2026 | By News Bureau | 134
GAIA AG and Daiichi Sankyo Europe form an exclusive partnership to commercialise lipodia, a digital therapeutic designed to help adults with Hypercholesterolemia adopt sustainable lifestyle changes for improved cardiovascular health.
Digitalization | 07/03/2026 | By News Bureau | 181
Biocon Academy Launches AI Certificate Programme in Life Sciences
Biocon Academy has launched the Syngene IBAB Certificate Programme in Artificial Intelligence in Life Sciences (SAILS), a first-of-its-kind initiative designed to build future-ready, industry-aligned AI talent for the life sciences sector and strengthen the intersection of biotechnology and digital innovation.
Digitalization | 05/03/2026 | By Akanki | 500
India-Rwanda Discussions Focus on AI, Bio-Manufacturing and Emerging Technologies
Union Minister Dr Jitendra Singh held talks with Rwanda’s ICT leadership to explore collaboration in Artificial Intelligence (AI), genomics, nuclear energy and deep-tech, highlighting startup partnerships and knowledge exchange to strengthen India-Rwanda cooperation.
Digitalization | 23/02/2026 | By News Bureau | 199
FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes
Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.
Digitalization | 22/01/2026 | By News Bureau | 247
HistoIndex, Houston Research Institute Collaborate to Enhance MASH Diagnosis Using AI
HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has entered into a strategic partnership with Houston Research Institute (HRI), a leading clinical research organization specialising in hepatology and gastroenterology, with a strong focus on metabolic liver disease.
Digitalization | 22/01/2026 | By Darshana | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy